...
首页> 外文期刊>Bone >Accumulation of bone strontium measured by in vivo XRF in rats supplemented with strontium citrate and strontium ranelate
【24h】

Accumulation of bone strontium measured by in vivo XRF in rats supplemented with strontium citrate and strontium ranelate

机译:体内X射线荧光法测定补充柠檬酸锶和雷奈酸锶的大鼠体内骨锶的积累

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Strontium ranelate is an approved pharmacotherapy for osteoporosis in Europe and Australia, but not in Canada or the United States. Strontium citrate, an alternative strontium salt, however, is available for purchase over-the-counter as a nutritional supplement. The effects of strontium citrate on bone are largely unknown. The study's objectives were 1) to quantify bone strontium accumulation in female Sprague Dawley rats administered strontium citrate (N= 7) and compare these levels to rats administered strontium ranelate (N= 6) and vehicle (N= 6) over 8. weeks, and 2) to verify an in vivo X-ray fluorescence spectroscopy (XRF) system for measurement of bone strontium in the rat. Daily doses of strontium citrate and strontium ranelate were determined with the intention to achieve equivalent amounts of elemental strontium. However, post-hoc analyses of each strontium compound conducted using energy dispersive spectrometry microanalysis revealed a higher elemental strontium concentration in strontium citrate than strontium ranelate. Bone strontium levels were measured at baseline and 8. weeks follow-up using a unique in vivo XRF technique previously used in humans. XRF measurements were validated against ex vivo measurements of bone strontium using inductively coupled plasma mass spectrometry. Weight gain in rats in all three groups was equivalent over the study duration. A two-way ANOVA was conducted to compare bone strontium levels amongst the three groups. Bone strontium levels in rats administered strontium citrate were significantly greater (p< 0.05) than rats administered strontium ranelate and vehicle. ANCOVA analyses were performed with Sr dose as a covariate to account for differences in strontium dosing. The ANCOVA revealed differences in bone strontium levels between the strontium groups were not significant, but that bone strontium levels were still very significantly greater than vehicle.
机译:雷奈酸锶在欧洲和澳大利亚是批准的用于骨质疏松症的药物疗法,但在加拿大或美国不是。柠檬酸锶,一种替代性锶盐,可作为营养补充剂在非处方药处购买。柠檬酸锶对骨骼的影响尚不清楚。这项研究的目的是:1)量化在服用柠檬酸锶(N = 7)的雌性Sprague Dawley大鼠中的骨锶积累,并将这些水平与在8周内施用雷奈酸锶(N = 6)和媒介物(N = 6)的大鼠进行比较, 2)验证用于测量大鼠骨锶的体内X射线荧光光谱(XRF)系统。确定柠檬酸锶和雷奈酸锶的日剂量,以达到等量的元素锶。但是,使用能量分散光谱微分析法对每种锶化合物进行事后分析表明,柠檬酸锶中元素锶的浓度高于雷奈酸锶。使用先前用于人类的独特体内XRF技术在基线和8周随访时测量骨锶水平。使用感应耦合等离子体质谱仪对骨锶的离体测量结果进行了XRF测量。在研究期间,所有三组大鼠的体重增加均相等。进行了双向方差分析,比较了三组之间的骨锶水平。枸酸锶大鼠的骨锶水平显着高于雷奈酸锶和赋形剂大鼠(p <0.05)。用锶剂量作为协变量进行ANCOVA分析,以解释锶剂量的差异。 ANCOVA揭示锶组之间骨锶水平的差异不显着,但骨锶水平仍显着高于媒介物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号